Webcast: Discussion of Results from Talactoferrin Phase 2 Trial in Severe Sepsis Print

Dial in numbers:

Participants in Europe:   0049 69 667775756
                                  0044 20 3003 2666

Participants in the U.S.: 1-646 843 4608

Link to Webcast